Pegylated-interferon-αα_2a in clinical practice: how to manage patients suffering from side effects

Author： Calvaruso Vincenza Mazza Marta Almasio Piero L

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.10, Iss.3, 2011-05, pp. : 429-435

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatitis C Treatment in Patients with Drug Addiction: Clinical Management of Interferon-Alpha-Associated Psychiatric Side Effects

Current Drug Abuse Reviews, Vol. 1, Iss. 2, 2008-06 ,pp. : 177-187

Bentham Science Publishers

Access to resources Recommend Favorite

Sexual Side Effects of Psychotropics; Implications for Clinical Practice

Current Psychopharmacology, Vol. 4, Iss. 1, 2015-04 ,pp. : 4-9

Bentham Science Publishers

Access to resources Recommend Favorite

Review of Instruments used in Clinical Practice to Assess Patients' Ability to Manage Medications

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 40, Iss. 1, 2010-03 ,pp. : 36-42

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence of Side Effects During Therapy with Different Types of Alpha Interferon: A Randomised Controlled Trial Comparing Recombinant Alpha 2b Versus Leukocyte Interferon in the Therapy of Naive Patients with Chronic Hepatitis C

Current Pharmaceutical Design, Vol. 8, Iss. 11, 2002-05 ,pp. : 977-980

Bentham Science Publishers

Access to resources Recommend Favorite

Structure, Biology, and Therapeutic Implications of Pegylated Interferon Alpha-2b

Current Pharmaceutical Design, Vol. 8, Iss. 24, 2002-11 ,pp. : 2139-2157

Bentham Science Publishers

Access to resources Recommend Favorite